The treatment, CYT387, appears to demonstrate an ability to render and maintain myelofibrosis patients transfusion independent for clinically-relevant periods, while also improving other symptoms, according to a phase I and phase II study.
Another key feature is a comparison recommendation engine for health plans that people can use during their open enrollment periods or when choosing an independent health plan.
He said that independent advisers had said there was no need to prepare for regular long periods of heavy snow fall in the future, but conceded there may still be severe events.